Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2018, Article ID 4568239, 2 pages
https://doi.org/10.1155/2018/4568239
Editorial

Peptide-Based Immunotherapeutics and Vaccines 2017

1Department of Immunology & O2, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain
2School of Life and Health Sciences, Aston University, Birmingham B4 7ET, UK
3ATR, LLC, Worcester, MA 01606, USA
4Department of Mycobacteriology, National Institute of Infectious Diseases, Higashi-Murayama, Tokyo 189-0002, Japan

Correspondence should be addressed to Pedro Reche; se.mcu.dem@gehcerap

Received 4 February 2018; Accepted 4 February 2018; Published 15 July 2018

Copyright © 2018 Pedro Reche et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [1 citation]

The following is the list of published articles that have cited the current article.

  • Andrey P. Rudometov, Anton N. Chikaev, Nadezhda B. Rudometova, Denis V. Antonets, Alexander A. Lomzov, Olga N. Kaplina, Alexander A. Ilyichev, and Larisa I. Karpenko, “Artificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope,” Vaccines, vol. 7, no. 3, pp. 83, 2019. View at Publisher · View at Google Scholar